Morgan Stanley names Eli Lilly a top pick, says it has best product outlook in pharma
[ad_1]
Analysts say that the new diabetes drug and new weight loss product could be a huge market opportunity for the company.
[ad_2]
[ad_1]
Analysts say that the new diabetes drug and new weight loss product could be a huge market opportunity for the company.
[ad_2]